BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36082023)

  • 1. Exploring the Value of Additional Primary Tumour Excision Combined with Systemic Therapy Administered in Different Sequences for Patients with de Novo Metastatic Breast Cancer.
    Zhu S
    Breast J; 2022; 2022():5049445. PubMed ID: 36082023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
    Gu Y; Wu G; Zou X; Huang P; Yi L
    Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.
    Lin C; Wu J; Ding S; Goh C; Andriani L; Lu S; Shen K; Zhu L
    J Natl Compr Canc Netw; 2019 Dec; 17(12):1521-1528. PubMed ID: 31805535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram Predicts the Role of Primary Tumor Surgery on
    Cui H; Dai L; Bao Y; Hu L; Zhou Z; Wang M; Lin S; Wu H; Ma X; Kang H
    Front Oncol; 2022; 12():819531. PubMed ID: 35600374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
    Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
    Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
    Wang K; Shi Y; Li ZY; Xiao YL; Li J; Zhang X; Li HY
    Eur J Surg Oncol; 2019 Aug; 45(8):1364-1372. PubMed ID: 30837102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
    Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
    Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis.
    Wang X; Liang N; Tian T; Zhang J; Hu P
    Technol Cancer Res Treat; 2022; 21():15330338221089937. PubMed ID: 35491730
    [No Abstract]   [Full Text] [Related]  

  • 10. The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions.
    Miyashita M; Balogun OB; Olopade OI; Huo D
    Sci Rep; 2023 Feb; 13(1):2880. PubMed ID: 36804591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
    Brandão M; Martins-Branco D; De Angelis C; Vuylsteke P; Gelber RD; Van Damme N; van Walle L; Ferreira AR; Lambertini M; Poggio F; Verhoeven D; Barbeaux A; Duhoux FP; Wildiers H; Caballero C; Awada A; Piccart-Gebhart M; Punie K; de Azambuja E
    Breast Cancer Res Treat; 2024 Jan; 203(2):351-363. PubMed ID: 37878152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of primary tumor surgery in
    Yang YS; Chen YL; Di GH; Jiang YZ; Shao ZM
    Transl Cancer Res; 2019 Apr; 8(2):614-625. PubMed ID: 35116794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic Pattern Discriminates Survival Benefit of Type of Surgery in Patients With
    Li K; Zhou C; Yu Y; Niu L; Zhang W; Wang B; He J; Ge G
    Front Surg; 2021; 8():696628. PubMed ID: 34805256
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
    Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
    Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis.
    Kim YJ; Jung SY; Kim K
    Sci Rep; 2019 Jun; 9(1):8527. PubMed ID: 31189932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.
    Si Y; Yuan P; Hu N; Wang X; Ju J; Wang J; Ma F; Luo Y; Zhang P; Li Q; Xu B
    Ann Surg Oncol; 2020 Apr; 27(4):1025-1033. PubMed ID: 31970572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De-novo metastatic breast cancers with or without primary tumor resection - A 10-year study.
    Co M; Ng J; Kwong A
    Cancer Treat Res Commun; 2019; 19():100118. PubMed ID: 30825858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional surgical treatment improves the prognosis in primary metastatic breast cancer patients with a single distant metastasis except for brain metastasis.
    Li X; Huang R; Ma L; Liu S; Zong X
    Breast; 2019 Jun; 45():104-112. PubMed ID: 30928762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery of the primary tumor does not improve survival in stage IV breast cancer.
    Dominici L; Najita J; Hughes M; Niland J; Marcom P; Wong YN; Carter B; Javid S; Edge S; Burstein H; Golshan M
    Breast Cancer Res Treat; 2011 Sep; 129(2):459-65. PubMed ID: 21713372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018.
    de Maar JS; Luyendijk M; Suelmann BBM; van der Kruijssen DEW; Elias SG; Siesling S; van der Wall E
    Breast Cancer Res Treat; 2023 Apr; 198(2):253-264. PubMed ID: 36648694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.